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Background: Obesity (abdominal adiposity) is a risk factor for cardiovascular diseases and the most used methods
to measure the adiposity are body mass index (BMI), waist circumference (WC), and sagittal abdominal diameter
(SAD).
Objective: To correlate BMI, WC, and SAD with biochemical parameters and blood pressure in adults.
Methods: A non-experimental exploratory/descriptive and cross sectional study was developed and it was assessed
133 subjects (59 men and 74 women) aging between 18 and 87 years. It was registered the patients’ weight (kg),
height (m), BMI (kg/m2), WC (cm) and SAD (cm), and these parameters were correlated with glycemia, triglycerides,
total cholesterol, HDL-c, LDL-c and blood pressure.
Results: After adjustment for gender and age, it was observed a positive correlation between SAD and systolic
arterial blood pressure (r = 0.20), glycemia (r = 0.20), triglycerides (r = 0.32), LDL (r = 0.26), total cholesterol (TC)
(r = 0.33), and a negative correlation with HDL-c (r = −0.21) (p < 0.05). It was observed a positive correlation between
WC and systolic arterial blood pressure (r = 0.14), triglycerides (r = 0.31), total cholesterol (r = 0.21), and a negative
correlation with HDL-c (r = −0.24) (p < 0.05). BMI showed a positive correlation with systolic arterial blood pressure
(r = 0.22), total cholesterol (r = 0.20), and triglycerides (r = 0.23) (p < 0.05).
Conclusion: SAD correlated with almost all the cardiovascular risk factors analyzed and it might be considered the
best predictor of abdominal fat and cardiovascular risk.
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According to the World Health Organization, obesity is
characterized by the accumulation of body fat and might
be responsible for the appearance of non-transmissible
chronic diseases (NTCD) [1]. According to data gathered
in 2001, about 60% of deaths were caused by NTCD [2].
In general, body mass index (BMI) is used to verify if
subjects are overweight or obese [3], without considering
muscle mass. It was observed that high BMI and ad-
vanced age increased the predisposition to hypertension
and diabetes mellitus (DM), which are two metabolic* Correspondence: erick_po@yahoo.com.br
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distribution, and reproduction in any mediumsyndrome (MS) components that are also associated to
cardiovascular disease (CVD) [4].
Abdominal adiposity is also a risk factor for the devel-
opment of CVDs [5,6], glucose intolerance [7,8], hyper-
tension and dyslipidemia [9]. Hence, it is necessary to
measure and quantify abdominal adiposity [10].
Computed tomography, magnetic resonance and dual-
energy x-ray absorptiometry are considered “gold standard”
to assess abdominal adiposity. However, these methods
are expensive and also expose subjects to radiation [11,12].
Therefore, some anthropometric measuring methods
like waist circumference (WC) and sagittal abdominal
diameter (SAD) [3] are used as abdominal obesity
markers due to the fact that they offer lower costs, and
are not only easy to measure but also harmless. They areMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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epidemiologic studies [13,14].
Waist circumference is the measurement that is more
commonly used to verify abdominal adiposity [15] be-
cause it is easy to be assessed by any person that received
little training and may be used to predict MS [16,17].
However, WC presents some limitations, because there
are subjects whose abdominal adiposity seems to move
the umbilical cord characterizing an “apron type
belly” [18].
SAD seems to be the best predictor of abdominal adi-
posity regarding cardiovascular morbity and mortality
[19]. When SAD is measured with the subject at supine
position, fat slides to the sides of the waist, thus
reflecting visceral adipose tissue [20], and making it a
more efficient method than the WC [16,21,22]. WC as
well as SAD, has specific measurement sites: the
narrowest waist measurement between thorax and waist
[23], the highest abdominal diameter site [24], umbilical
level [25] and the midpoint of iliac crests [26]. The last
one is the most commonly used [26,27] and it coincides
with the location of L4 and L5 [28,29].
Hence, this study aims to correlate SAD, WC, and
BMI with biochemical parameters as well as arterial
blood pressure of adults.
Methods
A non-experimental exploratory/descriptive and cross
sectional study was developed and it assessed 133 sub-
jects (59 men and 74 women) aging between 18 and
87 years in the cardiology and general clinic ambulatory
at “Dr. Jacob Casseb” health care Center in Agudos, São
Paulo, Brazil. All the subjects signed a free-consent
form, and the research project was approved by the
Research Ethics Committee (document no. CEP 191.038)
of the Paulista University (UNIP), Brazil.
Anthropometry
Body weight was measured with barefooted individuals
wearing as few clothes as possible. As for height, it was
measured with barefooted subjects with their feet to-
gether and heads held up high [30]. Both were measured
using a digital scale with a Welmy built-in stadiometer.
BMI was calculated dividing their weight by their
height and it was classified according to World Health
Organization, 2000 [31].
WC was measured using a Sanny inelastic and flexible
tape measure with the individual at a standing position.
It was assessed at the midpoint between the last rib and
iliac crest [31].
SAD was measured using an abdominal caliper
(Holtain Kahn Abdominal Caliper) with the individual
lying down in supine position at the iliac crests’ mid-
point. One caliper arm was placed at the back of thesubject and the other one was placed on his/her abdo-
men [26]. The adopted cutoffs to indicate cardiovas-
cular risk were > 23.1 cm for men and > 20.1 cm for
women [32].
Biochemical data and arterial blood pressure (ABP)
Biochemical data and ABP values were obtained from
the patients’ records, and it was taken into consideration
only the examinations that were performed up to one
month prior to the experiment’s data collection. Enzyme
colorimetric assay kits were used to quantify total chol-
esterol, glycemia, triglycerides (TG) and high density
lipoprotein (HDL-c). Low density lipoprotein (LDL-c)
was calculated by Friedewald equation [33].
ABP was assessed according to the VI Brazilian Arter-
ial Hypertension guidelines (2010) [34].
Statistical analysis
Data were expressed in mean ± standard deviation. Sam-
ple normality was tested by the Shapiro-Wilk test. It was
used the Student’s t test to compare the characteristics
of individuals of both genders. Pearson correlation (with
adjustment for gender and age) was used to correlate
BMI, WC, and SAD with biochemical and arterial blood
pressure parameters. Significance level was set at p < 0.05
and the software STATISTICA 6.0 was used for statistical
analysis.
Results
The present study assessed adult men and women. Men
showed higher values for weight and height when com-
pared to women and their BMI was classified as over-
weight. WC and SAD were altered; and Systolic arterial
blood pressure (SAP) as well as Diastolic arterial blood
pressure (DAP) were appropriate. Glycemia, LDL-c, total
cholesterol and triglycerides were altered and HDL was
adequate. Women showed a higher HDL-c concentra-
tions than men (Table 1).
It was observed a positive correlation between SAD
and systolic arterial blood pressure (r = 0.20), glycemia
(r = 0.20), triglycerides (r = 0.32), LDL (r = 0.26), total
cholesterol (TC) (r = 0.33), and a negative correlation with
HDL-c (r = −0.21) (p < 0.05). It was observed a positive
correlation between WC and systolic arterial blood
pressure (r = 0.14), triglycerides (r = 0.31), total choles-
terol (r = 0.21), and a negative correlation with HDL-c
(r = −0.24) (p < 0.05). BMI showed a positive correlation
with systolic arterial blood pressure (r = 0.22), total cho-
lesterol (r = 0.20) and triglycerides (r = 0.23) (p < 0.05)
(Figure 1).
Discussion
The results of the present study showed that SAD corre-
lated with more cardiovascular risk parameters than WC
Table 1 Characteristics of the individuals
Variables Total Men Women p value
Age (years) 56.9 ± 15.4 58.2 ± 15.4 56.0 ± 15.4 0.41
Weight (kg) 76.3 ± 15.2 82.4 ± 15.4 71.4 ± 13.1 0.00
Height (m) 1.6 ± 0.1 1.7 ± 0.1 1.6 ± 0.1 0.00
BMI (kg/m2) 29.0 ± 5.1 28.3 ± 4.7 29.5 ± 5.3 0.18
WC (cm) 101.2 ± 11.2 102.5 ± 10.1 100.2 ± 11.9 0.25
SAD (cm) 24.8 ± 4.3 24.9 ± 4.0 24.8 ± 4.6 0.84
SAP(mmHg) 128.0 ± 16.9 129.8 ± 15.6 126.6 ± 17.8 0.28
DAP (mmHg) 81.9 ± 12.7 82.2 ± 11.3 81.6 ± 13.8 0.79
Glycemia (mg/dl) 118.1 ± 54.4 116.7 ± 46.7 119.3 ± 60.1 0.78
HDL-c (mg/dl) 45.6 ± 8.7 43.5 ± 8.6 47.3 ± 8.5 0.02
LDL-c (mg/dl) 132.1 ± 31.8 1276 ± 31.0 135.4 ± 32.3 0.22
Total cholesterol (mg/dl) 206.5 ± 37.2 202.8 ± 36.5 209.5 ± 37.8 0.33
Triglycerides (mg/dl) 168.2 ± 114.8 187.9 ± 142.1 152.1 ± 84.1 0.09
Abbreviations: WC Waist circumference, SAD Sagittal abdominal diameter, SAP Systolic arterial blood pressure, DAP Diastolic Arterial blood pressure, HDL High
density lipoprotein, LDL Low density lipoprotein, BMI body mass index.
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cardiovascular parameters, respectively, whereas SAD
correlated with six out of seven parameters that were
assessed in this study. Just like the present study, other
researchers showed that SAD might be considered a
good marker for metabolic blood disorders [16,35].
In our study we observed that SAD is a better pre-
dictor of cardiovascular risk and metabolic syndrome
components, if compared to BMI and WC. Other stud-
ies presented the very same correlation regarding SAD.
It was observed that SAD was a better predictor for MS
[36], but this is not unanimous, since that others studies
showed that SAD, WC, and BMI had similar correlation
with the parameters analyzed [20,25].
WC has been the most commonly used abdominal
adiposity marker due to the fact that it is easy to per-
form, has a very low cost and does not expose individ-
uals to risks. The present study showed that WC
correlated with SAP, HDL-c, TC, TG, and it was moreFigure 1 Biochemical variables and arterial blood pressure correlation
*p < 0.05 / SAP: Systolic arterial blood pressure / DAP: Diastolic Arterial blood
Low density lipoprotein / TC: Total cholesterol / SAD: Sagittal abdominal diamefficient than BMI but not as much as SAD. Lopes de La
Terra et al., observed that increased WC was strongly
correlated with diabetes, but in the present study it was
only observed for SAD [37].
it was showed in a cross-sectional study of over one
hundred adults that only SAD was correlated with gly-
cemia, TG, and HDL-c whereas TC and LDL-c did not
correlate with any of the measurements [35]. In our
study SAD showed correlation with PAS, glycemia, TC,
TG, HDL-c and LDL-c. It was also more efficient than
WC and BMI, thus proving that it is an adiposity marker
that is more strongly correlated with cardiovascular risk
factors. Other studies showed that SAD was the only
anthropometric measurement that could predict insulin
resistance, hyperinsulinemia, and glycemia [16,38], thus
making this measurement a strong insulin resistance
marker, which was confirmed in our study.
We have assessed both WC and SAD to check which
one would be more accurate to estimate visceral fats with SAD, WC, and BMI (adjusted for gender and age).
pressure / HDL-c: High density lipoprotein / TG: Triglycerides / LDL-c:
eter / WC: Waist circumference / BMI: Body mass index.
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that were analyzed in the present study. VFT is the most
active and it is also an insulin-resistant tissue. It also
releases higher concentrations of adipokines that are
related to pro-inflammatory processes, and contributes
to the development of hypertension, insulin resistance,
metabolic syndrome, and cardiovascular diseases [39-42].
The subcutaneous fat tissue (SFT) presents properties of
intermediate order if compared to visceral fat, thus show-
ing lower adipokine secretion [43].
WC generally evaluates the abdominal extension and
it does not single out the two types of adipose tissue.
SAD can perform a more accurate evaluation of VFT
because its measurement is taken with the subject at
supine position and the SFT tends to slide to the sides
of the body due to its higher malleability. VFT is a more
rigid tissue so it does not slide and makes the SAD a
better analysis of VFT.
BMI is the most commonly used marker to assess nu-
tritional status. In our study it only correlated with SAP,
TC, and TG. Hence, BMI was not a strong marker to
demonstrate the influence of adiposity upon the risk
factor of cardiovascular diseases. It was already demon-
strated that BMI presented weaker correlation with VFT
if compared to SAD and WC [26,44]. Two other studies
showed that BMI was not as efficient as SAD and WC
to identify insulin resistance in men [16,45], which is in
line with our study.
Conclusion
We can conclude that SAD correlated with almost all
the cardiovascular risk factors analyzed at present study.
Thus, it is better to predict the quantity of abdominal fat
tissue and cardiovascular risk; and should be employed
in clinical practice.
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